NASDAQ:PFMT - Nasdaq - US71377E1055 - Common Stock - Currency: USD
3.56
-0.12 (-3.26%)
The current stock price of PFMT is 3.56 USD. In the past month the price increased by 19.66%. In the past year, price increased by 21.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.82 | 87.17B | ||
CVS | CVS HEALTH CORP | 10.77 | 86.64B | ||
LH | LABCORP HOLDINGS INC | 17.69 | 21.81B | ||
DGX | QUEST DIAGNOSTICS INC | 19.35 | 19.85B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.85 | 16.55B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 131.84 | 14.24B | ||
HIMS | HIMS & HERS HEALTH INC | 71.61 | 11.06B | ||
DVA | DAVITA INC | 15.33 | 10.70B | ||
CHE | CHEMED CORP | 23.73 | 8.18B | ||
GH | GUARDANT HEALTH INC | N/A | 6.30B | ||
CRVL | CORVEL CORP | 56.92 | 5.32B | ||
OPCH | OPTION CARE HEALTH INC | 26.01 | 5.28B |
Performant Financial Corp. engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. The company is headquartered in Pleasanton, California and currently employs 958 full-time employees. The company went IPO on 2012-08-10. The firm works with national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB) services, as well as claims-based services, which includes the audit and identification of improperly paid claims. The company also provides advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments. The firm offers these services in both government and commercial healthcare markets. The company provides audit, eligibility, and recovery services to identify improper healthcare payments. The firm provides its services to government and private clients, such as private healthcare and Center for Medicare and Medicaid Services (CMS).
PERFORMANT HEALTHCARE INC
4309 Hacienda Dr, Suite 110
Pleasanton CALIFORNIA 94551 US
CEO: Lisa C. Im
Employees: 958
Phone: 19259604800
The current stock price of PFMT is 3.56 USD. The price decreased by -3.26% in the last trading session.
The exchange symbol of PERFORMANT HEALTHCARE INC is PFMT and it is listed on the Nasdaq exchange.
PFMT stock is listed on the Nasdaq exchange.
9 analysts have analysed PFMT and the average price target is 7.14 USD. This implies a price increase of 100.56% is expected in the next year compared to the current price of 3.56. Check the PERFORMANT HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PERFORMANT HEALTHCARE INC (PFMT) has a market capitalization of 278.71M USD. This makes PFMT a Micro Cap stock.
PERFORMANT HEALTHCARE INC (PFMT) currently has 958 employees.
PERFORMANT HEALTHCARE INC (PFMT) has a support level at 3.55 and a resistance level at 3.69. Check the full technical report for a detailed analysis of PFMT support and resistance levels.
The Revenue of PERFORMANT HEALTHCARE INC (PFMT) is expected to grow by 8.54% in the next year. Check the estimates tab for more information on the PFMT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PFMT does not pay a dividend.
PERFORMANT HEALTHCARE INC (PFMT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.1).
ChartMill assigns a technical rating of 5 / 10 to PFMT. When comparing the yearly performance of all stocks, PFMT turns out to be only a medium performer in the overall market: it outperformed 64.61% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to PFMT. PFMT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months PFMT reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 16.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -7.99% | ||
ROE | -10.82% | ||
Debt/Equity | 0.11 |
ChartMill assigns a Buy % Consensus number of 82% to PFMT. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -39.4% and a revenue growth 8.54% for PFMT